Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |